RESUMEN
Nutritional education is pivotal in the medical nutritional therapy of type 2 diabetes mellitus (T2DM). The extended parallel process model (EPPM) is a health education method for inducing desirable health behaviours. The present study aimed to investigate the effect of nutritional education based on the EPPM in T2DM patients on knowledge, attitude, practice, anthropometric indices, glycaemic factors, lipid profile and adherence to the diabetic diet. A randomised, double-blind, controlled, factorial field trial was designed for T2DM patients aged 30-59 years (n 88). Participants were randomly allocated into four groups to receive EPPM-based nutritional education through gain framed message (GFM), loss framed message (LFM), their combination (G\LFM) or usual diabetic education in the control group (CG). Participants were assessed before and after the study duration. After 3 months of intervention, eighty participants finished the study. The EPPM-based intervention increased participants' knowledge, behavioural intention, perceived sensitivity, severity, self-efficacy (P < 0·001 for all) and response efficacy (P = 0·029) in comparison with CG. GFM (P = 0·004) and G\FLM (P = 0·034) reduced carbohydrate intake and LFM (P = 0·034) and G\LFM (P = 0·047) decreased fat intake. Between-group analysis indicated interventions reduced weight (P = 0·046), BMI (P = 0·038), fasting blood sugar (P = 0·030), 2-hour postprandial blood glucose (P = 0·027) and TAG (P = 0·002) in comparison with the CG. Results were NS for protein intake, waist and hip circumference, waist:hip ratio, HbA1c, total cholesterol, LDL and HDL. Nutritional education based on EPPM could increase the knowledge and awareness of T2DM patients. Also, it could be beneficial for blood glucose amendment. Further investigations are recommended.
Asunto(s)
Diabetes Mellitus Tipo 2 , Dieta para Diabéticos , Control Glucémico , Conocimientos, Actitudes y Práctica en Salud , Humanos , Persona de Mediana Edad , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/sangre , Método Doble Ciego , Masculino , Femenino , Adulto , Control Glucémico/métodos , Dieta para Diabéticos/métodos , Educación del Paciente como Asunto/métodos , Cooperación del Paciente , Glucemia/análisis , Glucemia/metabolismoRESUMEN
Introducción: La enfermedad de Diabetes Mellitus (DM)es considerada una de las enfermedades no transmisibles quecausa mayor morbimortalidad a nivel mundial y requiere deun elevado volumen de recursos y costes. Puesto que laforma de presentación más común es la diabetes mellitus tipo2 (DM2), se plantean nuevas estratégicas terapéuticas, comoes el uso de la dieta de ayuno intermitente como forma deafrontamiento de la enfermedad. Objetivo: Determinar los efectos del ayuno intermitenteen los pacientes con DM2, así como identificar los riesgos ybeneficios de la práctica de dicha dieta. Material y métodos: Se ha realizado una búsqueda bibliográfica en 6 bases de datos (Pubmed, Dialnet, Cochrane,Cinahl, Embase y Scopus), sobre los efectos que produce lapráctica del ayuno intermitente en personas con DM2. Se seleccionaron 16 artículos, que han sido analizados mediante lalectura crítica con el programa FLC 3.0. Resultados: Sedestacaron cambios positivos y estadísticamente significativos en los niveles de hemoglobina glicosilada (HbA1c), disminución de peso, disminución de los niveles de la glucosa en ayunas, así como los niveles de lípidosplasmáticos, el índice de masa corporal (IMC) y la circunferencia de la cintura. Como efectos adversos se observaron loseventos de hipoglucemia, pero no se vieron vinculados a lapráctica del ayuno, sino a las características personales decada paciente. Conclusiones: La dieta del ayuno intermitente en los pacientes con DM2 puede ser una herramienta eficaz que aportabeneficios a la salud de las personas siempre y cuando éstossean controlados y asesorados por profesionales adecuados. No obstante, se necesitan más estudios en humanos, con unamayor muestra de personas y más prolongados en el tiempopara obtener unos resultados más sólidos y concluyentes.(AU)
Introduction: The disease known as diabetes mellitus(DM) is generally considered one of the non communicablediseases worldwide and requires a high number of resourcesand costs for its treatment. Given that the most common formof diabetes mellitus type 2 (DM2), new therapeutical strategies are to be implemented, for instance the intermittent fasting as a way to deal with it.Objective: Determine the effects of the intermittent fasting on diagnosed DM2 patients as well as to identify the risksand benefits of carrying out this diet. Material and methods: Pubmed, Dialnet, Cochrane,Cinahl, Embase and Scopus were all used in the bibliographical research and documentation in regard with the effects produced by the implementation of the intermittentfasting on diagnosed DM2 patients. In addition, sixteen articles have been thoroughly analysed and examined throughthe FLC 3.0 Platform. Results: Positive and statistically significant changes stoodout on the levels of glycosylated haemoglobin (HbA1c),weight loss, lowering of the glucose and plasma lipids levelsduring the fasting period, a reduction of the body mass index(BMI) and the circumference of the waistline. On the contrary,hypoglycaemic events appeared as an adverse effect,nonetheless they were not associated with the practice of thefasting, but for the individual characteristics of the patients. Conclusions: The intermittent fasting on diagnosed DM2patients may suppose an efficient tool which brings healthbenefits as long as the patients are being under an adequate professional control and assessment. However, there is aneed of more longterm investigation and research on humans on a bigger scale with a larger sample in order to obtain more solid and conclusive results.(AU)
Asunto(s)
Humanos , Masculino , Femenino , Ayuno , Ayuno/efectos adversos , Diabetes Mellitus Tipo 2 , Diabetes Mellitus Tipo 2/terapia , Nutrición, Alimentación y Dieta , Pérdida de Peso , Glucemia , Dieta para Diabéticos/efectos adversos , Dieta para Diabéticos/métodos , Dieta para Diabéticos/estadística & datos numéricos , 52503RESUMEN
A traditional balanced Korean diet (K-diet) may improve energy, glucose, and lipid metabolism. To evaluate this, we conducted a randomized crossover clinical trial, involving participants aged 30-40 years, who were randomly assigned to two groups-a K-diet or westernized Korean control diet daily, with an estimated energy requirement (EER) of 1900 kcal. After a 4-week washout period, they switched the diet and followed it for 4 weeks. The carbohydrate, protein, and fat ratios based on energy intake were close to the target values for the K-diet (65:15:20) and control diet (60:15:25). The glycemic index of the control diet and the K-diet was 50.3 ± 3.6 and 68.1 ± 2.9, respectively, and daily cholesterol contents in the control diet and K-diet were 280 and 150 mg, respectively. Anthropometric and biochemical parameters involved in energy, glucose, and lipid metabolism were measured while plasma metabolites were determined using UPLC-QTOF-MS before and after the 4-week intervention. After the four-week intervention, both diets improved anthropometric and biochemical variables, but the K-diet significantly reduced them compared to the control diet. Serum total cholesterol, non-high-density lipoprotein cholesterol, and triglyceride concentrations were significantly lower in the K-diet group than in the control diet group. The waist circumference (p = 0.108) and insulin resistance index (QUICKI, p = 0.089) tended to be lower in the K-diet group than in the control diet group. Plasma metabolites indicated that participants in the K-diet group tended to reduce insulin resistance compared to those in the control diet group. Amino acids, especially branched-chain amino acids, tyrosine, tryptophan, and glutamate, and L-homocysteine concentrations were considerably lower in the K-diet group than in the control diet group (p < 0.05). Plasma glutathione concentrations, an index of antioxidant status, and 3-hydroxybutyric acid concentrations, were higher in the K-diet group than in the control diet group. In conclusion, a K-diet with adequate calories to meet EER alleviated dyslipidemia by decreasing insulin resistance-related amino acids and increasing ketones in the circulation of obese women.
Asunto(s)
Dieta Saludable/etnología , Dieta Saludable/métodos , Dislipidemias/dietoterapia , Índice Glucémico , Obesidad/dietoterapia , Adulto , Colesterol/sangre , Dieta para Diabéticos/etnología , Dieta para Diabéticos/métodos , Dieta con Restricción de Grasas/etnología , Dieta con Restricción de Grasas/métodos , Dislipidemias/sangre , Dislipidemias/etiología , Ingestión de Energía , Femenino , Humanos , Resistencia a la Insulina , Obesidad/sangre , Obesidad/complicaciones , República de Corea , Resultado del Tratamiento , Triglicéridos/sangreRESUMEN
We aimed to investigate the effects of a low-glycemic index (GI) diet on the body mass and blood glucose of patients with four common metabolic diseases by conducting a systematic review and meta-analysis of studies comparing a low-GI diet (LGID) and other types of diet. Search terms relating to population, intervention, comparator, outcomes, and study design were used to search three databases: PubMed, Embase, and the Cochrane Library. We identified 24 studies involving 2002 participants. Random-effects models were used for 16 studies in the meta-analysis and stratified analyses were performed according to the duration of the intervention. The systematic review showed that LGIDs slightly reduced body mass and body mass index (BMI) (p < 0.05). BMI improved more substantially after interventions of >24 weeks and there was no inter-study heterogeneity (I2 = 0%, p = 0.48; mean difference (MD) = -2.02, 95% confidence interval (CI): -3.05, -0.98). Overall, an LGID had superior effects to a control diet on fasting blood glucose (FBG) and glycosylated hemoglobin. When the intervention exceeded 30 days, an LGID reduced FBG more substantially (MD = -0.34, 95% CI: -0.55, -0.12). Thus, for patients with metabolic diseases, an LGID is more effective at controlling body mass and blood glucose than a high-GI or other diet.
Asunto(s)
Dieta para Diabéticos/métodos , Dieta/métodos , Índice Glucémico , Enfermedades Metabólicas/dietoterapia , Adolescente , Adulto , Glucemia/metabolismo , Índice de Masa Corporal , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Masculino , Enfermedades Metabólicas/sangre , Persona de Mediana Edad , Adulto JovenRESUMEN
The objective of this scoping review was to identify and characterize studies examining the effect of nutrition management interventions and effectiveness of medical nutrition therapy to improve nutrition-related outcomes in children and adolescents with type 1 diabetes. An in-depth electronic search was conducted by a medical librarian in six databases: Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, The Cumulative Index to Nursing and Allied Health Literature, and Web of Science Core Collection. The literature search resulted in 5,122 records, and five records were identified through hand search. Of these 5,127 records, 22 articles and eight systematic reviews met our inclusion criteria. An equal number of the studies were experimental (ie, randomized or nonrandomized controlled trials, or noncontrolled trials) (n = 11) and observational (cohort, case-control, and cross-sectional) (n = 11) with the remaining studies being systematic reviews/meta-analyses (n = 8). Most of these studies were conducted in United States or Europe. Based on this scoping review, the majority of studies focus on either carbohydrate counting or evaluation of dietary intake patterns with little emphasis on tailored patient education/counseling services specifically designed to meet a young child's or his/her family's individual needs. Indeed, only four studies in this scoping review used dietary counseling and/or medical nutrition therapy. As such, there remains a significant gap in the literature as it relates to the efficacy and long-term management implications of tailored nutrition interventions in young children with type 1 diabetes.
Asunto(s)
Diabetes Mellitus Tipo 1/dietoterapia , Dieta para Diabéticos/métodos , Terapia Nutricional/métodos , Adolescente , Niño , Preescolar , Ensayos Clínicos como Asunto , Consejo , Dieta Baja en Carbohidratos/métodos , Carbohidratos de la Dieta/análisis , Ingestión de Alimentos , Femenino , Humanos , Masculino , Estudios Observacionales como Asunto , Educación del Paciente como AsuntoRESUMEN
Unhealthy behaviours, including diet and physical activity, coupled with genetic predisposition, drive type 2 diabetes (T2D) occurrence and severity; the present review aims to summarise the most recent nutritional approaches in T2D, outlining unmet needs. Guidelines consistently suggest reducing energy intake to counteract the obesity epidemic, frequently resulting in sarcopenic obesity, a condition associated with poorer metabolic control and cardiovascular disease. Various dietary approaches have been proposed with largely similar results, with a preference for the Mediterranean diet and the best practice being the diet that patients feel confident of maintaining in the long term based on individual preferences. Patient adherence is indeed the pivotal factor for weight loss and long-term maintenance, requiring intensive lifestyle intervention. The consumption of nutritional supplements continues to increase even if international societies do not support their systematic use. Inositols and vitamin D supplementation, as well as micronutrients (zinc, chromium, magnesium) and pre/probiotics, result in modest improvement in insulin sensitivity, but their use is not systematically suggested. To reach the desired goals, patients should be actively involved in the collaborative development of a personalised meal plan associated with habitual physical activity, aiming at normal body weight and metabolic control.
Asunto(s)
Restricción Calórica/métodos , Diabetes Mellitus Tipo 2/terapia , Dieta para Diabéticos/métodos , Suplementos Dietéticos , Terapia Nutricional/tendencias , Dieta Mediterránea , Ejercicio Físico , Humanos , Cooperación del PacienteRESUMEN
The prevalence of Type 2 diabetes (T2D) is increasing, which creates a large economic burden. Diet is a critical factor in the treatment and management of T2D; however, there are a large number of dietary approaches and a general lack of consensus regarding the efficacy of each. Therefore, the purpose of this narrative review is twofold: (1) to critically evaluate the effects of various dietary strategies on diabetes management and treatment, such as Mediterranean diet, plant-based diet, low-calorie and very low-calorie diets, intermittent fasting, low-carbohydrate and very low-carbohydrate diets, and low glycemic diets and (2) to examine several purported supplements, such as protein, branched-chain amino acids, creatine, and vitamin D to improve glucose control and body composition. This review can serve as a resource for those wanting to evaluate the evidence supporting the various dietary strategies and supplements that may help manage T2D.
Asunto(s)
Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos/métodos , Suplementos Dietéticos , Manejo de la Enfermedad , HumanosRESUMEN
Postprandial hyperglycemia (PPHG) is strongly linked with the future development of cardiovascular complications in type 2 diabetes (T2D). Hence, reducing postprandial glycemic excursions is essential in T2D treatment to slow progressive deficiency of ß-cell function and prevent cardiovascular complications. Most of the metabolic processes involved in PPHG, i.e., ß-cell secretory function, GLP-1 secretion, insulin sensitivity, muscular glucose uptake, and hepatic glucose production, are controlled by the circadian clock and display daily oscillation. Consequently, postprandial glycemia displays diurnal variation with a higher glycemic response after meals with the same carbohydrate content, consumed at dusk compared to the morning. T2D and meal timing schedule not synchronized with the circadian clock (i.e., skipping breakfast) are associated with disrupted clock gene expression and is linked to PPHG. In contrast, greater intake in the morning (i.e., high energy breakfast) than in the evening has a resetting effect on clock gene oscillations and beneficial effects on weight loss, appetite, and reduction of PPHG, independently of total energy intake. Therefore, resetting clock gene expression through a diet intervention consisting of meal timing aligned to the circadian clock, i.e., shifting most calories and carbohydrates to the early hours of the day, is a promising therapeutic approach to improve PPHG in T2D. This review will focus on recent studies, showing how a high-energy breakfast diet (Bdiet) has resetting and synchronizing actions on circadian clock genes expression, improving glucose metabolism, postprandial glycemic excursions along with weight loss in T2D.
Asunto(s)
Desayuno/fisiología , Péptidos y Proteínas de Señalización del Ritmo Circadiano/metabolismo , Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos/métodos , Ingestión de Energía/fisiología , Apetito/fisiología , Glucemia/metabolismo , Relojes Circadianos/fisiología , Diabetes Mellitus Tipo 2/fisiopatología , Conducta Alimentaria/fisiología , Humanos , Hiperglucemia , Comidas/fisiología , Periodo Posprandial/fisiología , Factores de Tiempo , Pérdida de Peso/fisiologíaRESUMEN
The increased prevalence of obese, pregnant women who have a higher risk of glucose intolerance warrants the need for nutritional interventions to improve maternal glucose homeostasis. In this study, the effect of a low-glycemic load (GL) (n = 28) was compared to a high-GL (n = 34) dietary intervention during the second half of pregnancy in obese women (body mass index (BMI) > 30 or a body fat >35%). Anthropometric and metabolic parameters were assessed at baseline (20 week) and at 28 and 34 weeks gestation. For the primary outcome 3h-glucose-iAUC (3h-incremental area under the curve), mean between-group differences were non-significant at every study timepoint (p = 0.6, 0.3, and 0.8 at 20, 28, and 34 weeks, respectively) and also assessing the mean change over the study period (p = 0.6). Furthermore, there was no statistically significant difference between the two intervention groups for any of the other examined outcomes (p ≥ 0.07). In the pooled cohort, there was no significant effect of dietary GL on any metabolic or anthropometric outcome (p ≥ 0.2). A post hoc analysis comparing the study women to a cohort of overweight or obese pregnant women who received only routine care showed that the non-study women were more likely to gain excess weight (p = 0.046) and to deliver large-for-gestational-age (LGA) (p = 0.01) or macrosomic (p = 0.006) infants. Thus, a low-GL diet consumed during the last half of pregnancy did not improve pregnancy outcomes in obese women, but in comparison to non-study women, dietary counseling reduced the risk of adverse outcomes.
Asunto(s)
Dieta Baja en Carbohidratos/métodos , Dieta para Diabéticos/métodos , Carga Glucémica/fisiología , Obesidad/dietoterapia , Complicaciones del Embarazo/dietoterapia , Adulto , Antropometría , Área Bajo la Curva , Peso al Nacer , Glucemia/metabolismo , Índice de Masa Corporal , Femenino , Edad Gestacional , Ganancia de Peso Gestacional , Intolerancia a la Glucosa/sangre , Intolerancia a la Glucosa/complicaciones , Intolerancia a la Glucosa/dietoterapia , Humanos , Recién Nacido , Fenómenos Fisiologicos Nutricionales Maternos , Obesidad/sangre , Obesidad/complicaciones , Embarazo , Complicaciones del Embarazo/sangre , Resultado del Embarazo , Resultado del Tratamiento , Adulto JovenRESUMEN
Advice on dietary intake is an essential first line intervention for the management of gestational diabetes mellitus (GDM). Digital tools such as web-based and smartphone apps have been suggested to provide a novel way of providing information on diet for optimal glucose regulation in women with GDM. This systematic review explores the effectiveness and usability of digital tools designed to support dietary self-management of GDM. A systematic search of Medline, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, and Scopus using key search terms identified 1476 papers reporting research studies, of which 16 met the specified inclusion criteria. The quality of the included studies was assessed using the ErasmusAGE Quality Score or the Mixed Methods Appraisal Tool (MMAT) version 2018. The findings show that the adoption of digital tools may be an effective approach to support self-management relating to healthy diet, health behaviour, and adherence to therapy in women with GDM as a usable intervention. However, there is a lack of evidence concerning the effectiveness of tools to support the dietary management of GDM. Consideration for ethnic specific dietary advice and evidence-based frameworks in the development of effective digital tools for dietary management of GDM should be considered as these aspects have been limited in the studies reviewed.
Asunto(s)
Diabetes Gestacional/dietoterapia , Aplicaciones Móviles , Automanejo , Dieta para Diabéticos/métodos , Femenino , Humanos , Embarazo , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
BACKGROUND: Gestational diabetes mellitus (GDM) is associated with fetal overgrowth, and certain treatments are associated with an increased risk of macrosomia. However, there are limited data about the long-term effect of GDM treatment on childhood growth. METHODS: Cohort study of 816 women with GDM and their offspring delivered between 2009 and 2012. Childhood height and weight through age 3 were collected from the medical record and z-scores and body mass index (BMI) were calculated. We assessed the association between GDM treatment and childhood growth using linear mixed modeling. RESULTS: Treatment was divided into medical nutritional therapy (MNT) (nâ =â 293), glyburide (nâ =â 421), and insulin (nâ =â 102). At delivery, birthweight, z-score, and BMI were higher in the offspring of women treated with either glyburide or insulin compared to MNT. However, weight, z-score, and BMI were similar among all offspring at 6 months and 1, 2, and 3 years of age. After controlling for covariates, there were differences in the weight z-score (Pâ =â 0.01) over the 3-year period by treatment group, but no differences in weight (Pâ =â 0.06) or change in BMI (Pâ =â 0.28). Pairwise comparisons indicated that insulin was associated with more weight gain compared with MNT (0.69 kg; 95% CI, 0.10-1.28; Pâ =â 0.02) and glyburide was associated with a trend toward lower weight z-score compared with MNT (-0.24; 95% CI, -0.47 to 0.003; Pâ =â 0.05). CONCLUSION: Despite growth differences detected at birth, we observed no meaningful differences in childhood growth from 6 months to 3 years among treatment groups, including in the offspring of women with GDM treated with glyburide.
Asunto(s)
Desarrollo Infantil , Diabetes Gestacional/terapia , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Adulto , Peso al Nacer/efectos de los fármacos , Peso al Nacer/fisiología , Desarrollo Infantil/efectos de los fármacos , Preescolar , Estudios de Cohortes , Diabetes Gestacional/dietoterapia , Diabetes Gestacional/tratamiento farmacológico , Dieta para Diabéticos/métodos , Femenino , Gliburida/uso terapéutico , Humanos , Lactante , Recién Nacido , Insulina/uso terapéutico , Masculino , Pennsylvania , Embarazo , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Fenómenos Fisiologicos de la Nutrición Prenatal , Estudios Retrospectivos , Aumento de Peso/efectos de los fármacos , Aumento de Peso/fisiología , Adulto JovenRESUMEN
This study aimed at designing a-diet high in slowly digestible starch (SDS) by carefully selecting high-SDS starchy products and to validate its implementation, acceptance, and impact on the postprandial glycemic response in patients with type 2 diabetes (T2D). Starchy products were screened and classified as being either high (high-SDS) or low (low-SDS) in SDS (in vitro SDS method). A randomized controlled cross-over pilot study was performed: Eight patients with T2D consumed randomly a high-SDS or a low-SDS diet for one week each, while their glycemic profile was monitored for 6 days. Based on 250 food product SDS analyses and dietary recommendations for patients with T2D, the high-SDS and low-SDS diets were designed. The high-SDS diet significantly increased SDS intake and the SDS/carbohydrates proportion compared to the low-SDS diet (61.6 vs. 11.6 g/day and 30% vs. 6%; p < 0.0001, respectively). Increasing the SDS/carbohydrate proportion to 50% of the meal was significantly correlated with a 12% decrease in tAUC0-120 min and a 14% decrease in the glycemic peak value (p < 0.001 for both). A high-SDS diet can be easily designed by carefully selecting commercial starchy products and providing relevant recommendations for T2D to improve their glycemic profile.
Asunto(s)
Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos/métodos , Digestión/efectos de los fármacos , Almidón/farmacocinética , Adolescente , Adulto , Anciano , Disponibilidad Biológica , Glucemia/efectos de los fármacos , Estudios Cruzados , Diabetes Mellitus Tipo 2/sangre , Estudios de Factibilidad , Femenino , Hemoglobina Glucada/efectos de los fármacos , Índice Glucémico , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Periodo Posprandial/efectos de los fármacos , Método Simple Ciego , Resultado del Tratamiento , Adulto JovenRESUMEN
Carbohydrate-restricted diets are increasingly recognized as options for dietary management of type 2 diabetes mellitus (T2DM). We investigated the effects of a carbohydrate-reduced high-protein (CRHP) and a conventional diabetes (CD) diet on oxidative stress and inflammation in weight stable individuals with T2DM. We hypothesized that the CRHP diet would improve markers of oxidatively generated RNA and DNA modifications as well as inflammatory parameters. Thirty participants with T2DM were randomized to 6 weeks of CRHP or CD dietary treatment (30/50 energy percentage (E%) carbohydrate, 30/17E% protein, 40/33E% fat), followed by a cross-over to the opposite diet for a subsequent 6-week period. All meals were provided during the study and body weight was controlled. Diurnal urine samples were collected after 4 weeks on each diet and oxidatively generated RNA and DNA modifications were measured as 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), respectively. Fasting concentrations of soluble urokinase plasminogen activator receptor, high-sensitivity C-reactive protein, tumor necrosis factor alpha and interleukin-6 were measured before and after 6 weeks of interventions. Compared with the CD diet, the CRHP diet increased 24-hour urinary excretion of 8-oxoGuo by 9.3% (38.6 ± 12.6 vs. 35.3 ± 11.0 nmol/24 h, p = .03), whereas 8-oxodG did not differ between diets (24.0 ± 9.5 vs. 24.8 ± 11.1 nmol/24 h, p = .17). Changes in plasma inflammatory parameters did not differ between CRHP and CD diets, all p ≥ .2. The clinical implications of increased RNA oxidation following a CRHP diet as well as long-term effects of carbohydrate-restriction on markers of oxidatively generated nucleic acid modifications should be a field of future study.
Asunto(s)
8-Hidroxi-2'-Desoxicoguanosina/orina , Diabetes Mellitus Tipo 2/orina , Dieta para Diabéticos/métodos , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono/efectos adversos , Guanosina/análogos & derivados , Ácidos Nucleicos/orina , Anciano , Glucemia/metabolismo , Índice de Masa Corporal , Peso Corporal , Proteína C-Reactiva/orina , Estudios Cruzados , Diabetes Mellitus Tipo 2/sangre , Femenino , Hemoglobina Glucada/metabolismo , Guanosina/orina , Humanos , Inflamación , Interleucina-6/orina , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Estrés Oxidativo , Receptores del Activador de Plasminógeno Tipo Uroquinasa/metabolismo , Factor de Necrosis Tumoral alfa/orinaRESUMEN
OBJECTIVE: The aim of this study was to compare the metabolic benefits of diabetes-specific formulas (DSF) high in monounsaturated fatty acids (MUFA) with standard formulas (STDF) in adult patients with type 1, type 2 diabetes or stress-induced hyperglycaemia. RESEARCH DESIGN AND METHODS: A systematic review and meta-analysis were conducted through a literature search using different electronic databases from the index date to December 2018. We included randomised controlled trials that assessed the health benefits of high MUFA DSF vs STDF. Included outcomes were glycaemic control, lipid metabolism and tolerance. Effect sizes were calculated as standardised mean differences (SMDs) (<0.4 were considered small, 0.4-0.7 moderate and >0.7 large). This systematic review was registered as CRD42018108931 on Prospero. RESULTS: Of 385 references reviewed, 18 studies involving 845 adults met our inclusion criteria and contributed to the meta-analysis. Use of a high MUFA DSF compared with a STDF was associated with a statistically significant decrease in peak of postprandial glucose [SMD -1.53, 95% confidence interval (CI) -2.44 to -0.61], incremental glucose response (SMD -1.19, 95% CI -1.71 to -0.68), area under the curve of plasma insulin (SMD -0.65, 95% CI -1.03 to -0.26), mean blood glucose level (SMD -0.41, 95% CI -0.63 to -0.19), glycosylated haemoglobin (HbA1c) change (SMD -0.63, 95% CI -1.21 to -0.05), glucose variability (SMD -0.93, -1.55 to -0.31), mean administered insulin dose (SMD -0.49, 95% CI -0.85 to -0.14), mean blood triglycerides (SMD -0.34, 95% CI -0.65 to -0.03) and increase of mean blood high-density lipoproteins (SMD +0.42, 95% CI 0.08 to 0.76). Non-significant differences were found for tolerance [odds ratio (OR) 0.95, 95% CI 0.87 to 1.05]. CONCLUSIONS: This meta-analysis shows that a DSF (oral supplements and tube feeds) high in MUFAs can improve glucose control and metabolic risk factors among patients with diabetes or stress-induced hyperglycaemia compared with a STDF.
Asunto(s)
Diabetes Mellitus Tipo 1/dietoterapia , Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos/métodos , Ácidos Grasos Monoinsaturados/administración & dosificación , Alimentos Formulados , Hiperglucemia/dietoterapia , Glucemia/metabolismo , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 2/sangre , Suplementos Dietéticos , Nutrición Enteral , Hemoglobina Glucada/metabolismo , Control Glucémico/métodos , Humanos , Hiperglucemia/sangre , Insulina/sangre , Metabolismo de los Lípidos , Periodo Posprandial , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
Gestational diabetes (GDM) is hyperglycemia that is recognized for the first time during pregnancy. GDM is associated with a wide range of short- and long-term adverse health consequences for both mother and offspring. It is a complex disease with a multifactorial etiology, with disturbances in glucose, lipid, inflammation and gut microbiota. Consequently, its management is complex, requiring patients to self-manage their diet, lifestyle and self-care behaviors in combination with use of insulin. In addition to nutritional recommendations for all pregnant women, special attention to dietary carbohydrate (CHO) amount and type on glucose levels is especially important in GDM. Dietary CHO are diverse, ranging from simple sugars to longer-chain oligo- and poly- saccharides which have diverse effects on blood glucose, microbial fermentation and bowel function. Studies have established that dietary CHO amount and type can impact maternal glucose and nutritional recommendations advise women with GDM to limit total intake or choose complex and low glycemic CHO. However, robust maternal and infant benefits are not consistently shown. Novel approaches which help women with GDM adhere to dietary recommendations such as diabetes-specific meal replacements (which provide a defined and complete nutritional composition with slowly-digested CHO) and continuous glucose monitors (which provide unlimited monitoring of maternal glycemic fluctuations) have shown benefits on both maternal and neonatal outcomes. Continued research is needed to understand and develop tools to facilitate patient adherence to treatment goals, individualize interventions and improve outcomes.
Asunto(s)
Diabetes Gestacional/dietoterapia , Dieta para Diabéticos/métodos , Carbohidratos de la Dieta/análisis , Atención Prenatal/métodos , Glucemia/efectos de los fármacos , Diabetes Gestacional/sangre , Diabetes Gestacional/etiología , Femenino , Índice Glucémico/efectos de los fármacos , Humanos , Fenómenos Fisiologicos Nutricionales Maternos , EmbarazoRESUMEN
BACKGROUND: Medically-tailored meal programs that provide home-delivered medically-appropriate food are an emerging intervention when type 2 diabetes co-occurs with food insecurity (limited or uncertain access to nutritious food owing to cost). We sought to understand the experiences of medically-tailored meal program participants. METHODS: We conducted semi-structured interviews with participants in a randomized trial of medically-tailored meals (NCT02426138) until reaching content saturation. Participants were adults (age > 20 years) with type 2 diabetes in eastern Massachusetts, and the interviews were conducted from April to July 2017. Interviews were transcribed verbatim and coded by two independent reviewers. We determined emergent themes using content analysis. RESULTS: Twenty individuals were interviewed. Their mean age was 58 (SD: 13) years, 60.0% were women, 20.0% were non-Hispanic black, and 15.0% were Hispanic. Key themes were 1) satisfaction and experience with medically-tailored meals 2) food preferences and cultural appropriateness, 3) diabetes management and awareness, and 4) suggestions for improvement and co-interventions. Within these themes, participants were generally satisfied with medically-tailored meals and emphasized the importance of receiving culturally appropriate food. Participants reported several positive effects of medically-tailored meals, including improved quality of life and ability to manage diabetes, and stress reduction. Participants suggested combining medically-tailored meals with diabetes self-management education or lifestyle interventions. CONCLUSIONS: Individuals with diabetes and food insecurity expressed satisfaction with the medically-tailored meal program, and reported that participation reduced stress and the burden of diabetes management. Suggestions to help ensure the success of medically-tailored meal programs included a strong emphasis on culturally acceptability and accommodating taste preferences for provided foods, and combining medically-tailored meals with diabetes education or lifestyle intervention. TRIAL REGISTRATION: ClinicalTrials.gov NCT02426138.
Asunto(s)
Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/epidemiología , Dieta para Diabéticos/métodos , Servicios Dietéticos/métodos , Abastecimiento de Alimentos/métodos , Comidas/psicología , Calidad de Vida , Estudios Cruzados , Femenino , Estudios de Seguimiento , Conductas Relacionadas con la Salud , Humanos , Estilo de Vida , Masculino , Massachusetts/epidemiología , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Pronóstico , Investigación Cualitativa , Encuestas y CuestionariosRESUMEN
Unhealthy weight gain and diabetes are global challenges that threaten not only the well-beings of hundreds of millions of persons but also the global economy. The authors in this article describe two overlapping stories, one is about a 150-year-old diet, known as the Banting Diet, which is similar to the Atkins or Keto Diet, and the other is about a provider-patient relationship story that helped the patient make lifestyle modifications that were effective in significant weight loss, improved quality of life, and reduced need for exogenous insulin for Type 2 diabetes. Both of the stories are from England but might be useful worldwide.
Asunto(s)
Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos/historia , Dieta para Diabéticos/métodos , Historia del Siglo XIX , Historia del Siglo XXI , Humanos , Relaciones Médico-Paciente , Reino Unido , Pérdida de PesoRESUMEN
We assessed the effects of increased Ca consumption from fat-free milk in an energy-restricted diet and educational activities in the metabolic control of overweight type 2 diabetes mellitus (T2DM) patients. Fourteen subjects with T2DM (BMI 29·4 (sd 4·5) kg/m2, low habitual Ca consumption (<600 mg/d)) were included in this randomised, crossover clinical trial. Subjects were randomly allocated to one of the two interventions: drink containing 700 mg of Ca (DAIR) or drink containing 0 mg of Ca (CONT) for ninety consecutive days each. Energy-restricted diets (-500 kcal/d; -2092 kJ/d), containing 800 mg of Ca from dietary sources/d, were prescribed for both groups. Questionnaires were applied at baseline and at the end of the study to assess the subjects' knowledge on the disease and on self-care, biochemical variables and physical activity. Blood pressure, food intake, body composition and anthropometry were assessed at baseline, days 45 and 90. There was a higher reduction of body fat %, waist circumference, hip circumference, neck circumference, waist:hip ratio, sagittal abdominal diameter, diastolic/systolic blood pressure and an increase in fat-free mass % in DAIR than in CONT. Uric acid, fasting glucose, Hb1Ac, parathyroid hormone and alanine aminotransferase concentrations reduced and vitamin D concentration increased after 90 d in DAIR compared with CONT. The consumption of energy-restricted diet containing 1200 mg Ca/d seems to favour metabolic control in subjects with T2DM. The educational activities increased the knowledge on the disease care.
Asunto(s)
Calcio de la Dieta/administración & dosificación , Restricción Calórica/métodos , Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos/métodos , Sobrepeso/dietoterapia , Educación del Paciente como Asunto/métodos , Adulto , Animales , Glucemia/análisis , Composición Corporal , Peso Corporal , Estudios Cruzados , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/psicología , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Leche/química , Sobrepeso/complicaciones , Sobrepeso/psicología , Aceptación de la Atención de Salud/psicología , Autocuidado/métodos , Autocuidado/psicología , Resultado del Tratamiento , Circunferencia de la Cintura , Relación Cintura-CaderaRESUMEN
BACKGROUND: The present study investigated the effects of fat-protein (CFP) counting in addition to carbohydrate (CARB) counting for calculating prandial insulin dosage on blood glucose profile in patients with type 1 diabetes (T1D) on basal-bolus insulin therapy. METHODS: In this single centre, cross-over, randomised, controlled study, control meal (SM: standard meal using a carbohydrate counting method) and three test meals (HPM: high protein meal using a carbohydrate counting method; HPFM-a: high protein-fat meal using a carbohydrate counting method; HPFM-b: high protein-fat meal using a carbohydrate and fat-protein counting method) were compared on postprandial early (0-120 min), late (120-240 min) and total (0-240 min) glucose response in 30 patients with T1D, aged 16-18 years. RESULTS: The glucose levels of 0-90 min did not change after different meal consumptions (P > 0.05), whereas 120-240 min glucose levels were higher after HPFM-a consumption compared to HPFM-b consumption (P < 0.05). There were no significant differences between meals with respect to the early postprandial glucose response (0-120 min) (P = 0.405). In late response (120-240 min), HPFM-b [area under the curve (AUC) = 20 609 (582) mg dL-1 × dk] was significantly lower than SM [AUC = 24 092 (9015) mg dL-1 × dk], HPM [AUC = 24 072 (5853) mg dL-1 × dk] and HPFM-a [AUC = 25 986 (6979) mg dL-1 × dk] (P = 0.032). CONCLUSIONS: Meal-related insulin dosing based on carbohydrate plus fat/protein counting has given positive results in the postprandial glycaemic profile as a result of lower postprandial glycaemic levels compared to conventional carbohydrate counting in patients with T1D after a high protein-fat meal.
Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Dieta para Diabéticos/métodos , Hipoglucemiantes/administración & dosificación , Insulina/administración & dosificación , Comidas/fisiología , Adolescente , Glucemia/metabolismo , Estudios Cruzados , Diabetes Mellitus Tipo 1/sangre , Carbohidratos de la Dieta/análisis , Grasas de la Dieta/análisis , Proteínas en la Dieta/análisis , Femenino , Humanos , Masculino , Periodo Posprandial/fisiología , Resultado del TratamientoRESUMEN
INTRODUCTION: Recommendations on energy intake are key in body weight management to improve glycaemic control in people with type 2 diabetes (T2D). International clinical guidelines recommend a variety of eating patterns to promote energy restriction as the primary dietetic approach to body weight control in managing T2D. In addition, individualised guidance on self-monitoring carbohydrate intake to optimise meal timing and food choices (eg, basic carbohydrate counting (BCC)) is recommended to achieve glycaemic control. However, the evidence for this approach in T2D is limited. The objective of this study was to compare the effect of an educational programme in BCC as add-on to the usual dietary care on glycaemic control in people with T2D. METHODS AND ANALYSES: The study is designed as a randomised, controlled trial with a parallel-group design. The study duration is 12 months with data collection at baseline, and after 6 and 12 months. We plan to include 226 adults with T2D. Participants will be randomised to one of two interventions: (1) BCC as add-on to usual dietary care or (2) usual dietary care. The primary outcome is changes in glycated haemoglobin A1c or mean amplitude of glycaemic excursions from baseline and after 6-month intervention between and within study groups. Further outcome measures include changes in time in range, body weight and composition, lipid profile, blood pressure, mathematical literacy skills, carbohydrate estimation accuracy, dietary intake, diet-related quality of life, perceived competencies in diet and diabetes and perceptions of an autonomy supportive dietician-led climate, physical activity and urinary biomarkers. ETHICS AND DISSEMINATION: The protocol has been approved by the Ethics Committee of the Capital Region, Copenhagen, Denmark. Study findings will be disseminated widely through peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: NCT03623139.